VitaNova Life Sciences Corp (VNOV)
↓ Download CSV- Sector Wholesale Trade
- Incorporated NV
- Fiscal year ends Apr 30
In fiscal 2025, VitaNova Life Sciences Corp reported revenue of $2.66M, up 366.5% from the prior year. The company was profitable, with a net margin of 32.0% and a gross margin of 59.2%. It held $2.26M in total assets against $347.6K in total liabilities.
Key ratios (FY2025)
59.2%
Gross margin
45.4%
Operating margin
32.0%
Net margin
44.6%
Return on equity
+366.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.66M | $570.7K | $38.0K | — | — | — | — | — | — |
| Cost of Revenue | $1.09M | $193.0K | $0 | — | — | — | $0 | $0 | — |
| Gross Profit | $1.58M | $377.7K | $38.0K | — | — | — | $0 | $0 | $0 |
| Operating Income | $1.21M | $205.6K | -$24.2K | -$13.4K | -$52.1K | -$72.3K | -$71.8K | -$48.6K | — |
| Net Income | $850.7K | $140.9K | -$24.2K | $139.7K | -$52.1K | -$72.3K | -$106.2K | -$1.6K | -$7.2K |
| EPS (Diluted) | $0.03 | $0.01 | $0.00 | $0.02 | $-0.01 | — | — | — | — |
| Total Assets | $2.26M | $1.19M | $8.7K | $23.1K | $0 | $0 | $0 | $47.8K | $2.4K |
| Total Liabilities | $347.6K | $136.9K | $67.9K | $58.1K | $174.7K | $122.6K | $50.2K | $5.6K | $7.9K |
| Shareholders' Equity | $1.91M | $1.06M | -$59.2K | -$35.0K | -$174.7K | -$122.6K | -$50.2K | $42.2K | -$3.7K |
| Cash & Equivalents | — | — | $8.7K | $23.1K | $0 | $0 | $0 | $4.4K | $205 |
| Operating Cash Flow | $192.8K | -$375.9K | -$18.4K | $4.1K | -$42.3K | -$53.6K | -$49.1K | -$9.3K | -$6.5K |
| Shares Outstanding | 25.01M | 25.01M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 3.50M |